Brown K - Search Results

1

Accelerator mass spectrometry for biomedical research.

Brown K, Dingley KH, Turteltaub KW. Brown K, et al. Methods Enzymol. 2005;402:423-43. doi: 10.1016/S0076-6879(05)02014-8. Methods Enzymol. 2005. PMID: 16401518 Review.

2

Tamoxifen DNA damage detected in human endometrium using accelerator mass spectrometry.

Martin EA, Brown K, Gaskell M, Al-Azzawi F, Garner RC, Boocock DJ, Mattock E, Pring DW, Dingley K, Turteltaub KW, Smith LL, White IN. Martin EA, et al. Among authors: brown k. Cancer Res. 2003 Dec 1;63(23):8461-5. Cancer Res. 2003. PMID: 14679010

3

A novel 14C-postlabeling assay using accelerator mass spectrometry for the detection of O6-methyldeoxy-guanosine adducts.

Tompkins EM, Farmer PB, Lamb JH, Jukes R, Dingley K, Ubick E, Turteltaub KW, Martin EA, Brown K. Tompkins EM, et al. Among authors: brown k. Rapid Commun Mass Spectrom. 2006;20(5):883-91. doi: 10.1002/rcm.2370. Rapid Commun Mass Spectrom. 2006. PMID: 16470516 Free article.

4

Structural characterization of carcinogen-modified oligodeoxynucleotide adducts using matrix-assisted laser desorption/ionization mass spectrometry.

Brown K, Harvey CA, Turteltaub KW, Shields SJ. Brown K, et al. J Mass Spectrom. 2003 Jan;38(1):68-79. doi: 10.1002/jms.401. J Mass Spectrom. 2003. PMID: 12526008

5

Tamoxifen forms DNA adducts in human colon after administration of a single [14C]-labeled therapeutic dose.

Brown K, Tompkins EM, Boocock DJ, Martin EA, Farmer PB, Turteltaub KW, Ubick E, Hemingway D, Horner-Glister E, White IN. Brown K, et al. Cancer Res. 2007 Jul 15;67(14):6995-7002. doi: 10.1158/0008-5472.CAN-07-0913. Cancer Res. 2007. PMID: 17638912

6

Identification of human CYP forms involved in the activation of tamoxifen and irreversible binding to DNA.

Boocock DJ, Brown K, Gibbs AH, Sanchez E, Turteltaub KW, White IN. Boocock DJ, et al. Among authors: brown k. Carcinogenesis. 2002 Nov;23(11):1897-901. doi: 10.1093/carcin/23.11.1897. Carcinogenesis. 2002. PMID: 12419838

7

Techniques: the application of accelerator mass spectrometry to pharmacology and toxicology.

White IN, Brown K. White IN, et al. Among authors: brown k. Trends Pharmacol Sci. 2004 Aug;25(8):442-7. doi: 10.1016/j.tips.2004.06.009. Trends Pharmacol Sci. 2004. PMID: 15276714 Review.

8

Applications of accelerator mass spectrometry for pharmacological and toxicological research.

Brown K, Tompkins EM, White IN. Brown K, et al. Mass Spectrom Rev. 2006 Jan-Feb;25(1):127-45. doi: 10.1002/mas.20059. Mass Spectrom Rev. 2006. PMID: 16059873 Review.

9

Distribution and metabolism of [14C]-resveratrol in human prostate tissue after oral administration of a "dietary-achievable" or "pharmacological" dose: what are the implications for anticancer activity?

Cai H, Scott EN, Britton RG, Parrott E, Ognibene TJ, Malfatti M, Khan M, Steward WP, Brown K. Cai H, et al. Among authors: brown k. Am J Clin Nutr. 2021 May 8;113(5):1115-1125. doi: 10.1093/ajcn/nqaa414. Am J Clin Nutr. 2021. PMID: 33675348 Free PMC article.

10

Methods for the detection of DNA adducts.

Brown K. Brown K. Methods Mol Biol. 2012;817:207-30. doi: 10.1007/978-1-61779-421-6_11. Methods Mol Biol. 2012. PMID: 22147575

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,666 results

Search Page